FTO and acute myeloid leukemia: Huang et al. find that artificially developed FTO inhibitors FB23 and FB23-2 can directly bind to FTO, selectively inhibit the m6A demethylase activity of FTO, and significantly inhibit cell proliferation in human acute myeloid leukaemia (Huang et al., 2019).